Perspective Therapeutics (NYSE:CATX) Given “Outperform” Rating at Wedbush
Wedbush reiterated their outperform rating on shares of Perspective Therapeutics (NYSE:CATX – Free Report) in a report issued on Wednesday morning,RTT News reports. Wedbush currently has a $11.00 target price on the stock. Other equities analysts have also recently issued reports about the company. HC Wainwright reissued a “buy” rating and set a $10.00 price […]
Wedbush reiterated their outperform rating on shares of Perspective Therapeutics (NYSE:CATX – Free Report) in a report issued on Wednesday morning,RTT News reports. Wedbush currently has a $11.00 target price on the stock. Other equities analysts have also recently issued reports about the company. HC Wainwright reissued a “buy” rating and set a $10.00 price […]
